Your browser doesn't support javascript.
loading
Poor survival after resection of early gastric cancer: extremes of survivorship analysis reveal distinct genomic profile.
Datta, J; Da Silva, E M; Kandoth, C; Song, T; Russo, A E; Hernandez, J M; Taylor, B S; Janjigian, Y Y; Tang, L H; Solit, D B; Strong, V E.
Afiliação
  • Datta J; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Da Silva EM; Department of Surgery, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, Florida, USA.
  • Kandoth C; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Song T; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Russo AE; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Hernandez JM; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Taylor BS; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Janjigian YY; Thoracic and Oncologic Surgery Branch, National Institutes of Health, Bethesda, Maryland, USA.
  • Tang LH; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Solit DB; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Strong VE; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA.
Br J Surg ; 107(1): 14-19, 2020 01.
Article em En | MEDLINE | ID: mdl-31763684
A subset of patients with early gastric cancer demonstrate early recurrence and poor survival despite margin-negative resection. This study used an extremes-of-survivorship approach to identify an association between TP53 hotspot mutations co-occurring with loss of heterozygosity and unexpectedly poor survival in early gastric cancer. This distinct genomic profile may be a novel biomarker of poor survival in patients with completely resected early gastric cancer, and warrants large-scale validation. Promising, validation needed.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Proteína Supressora de Tumor p53 / Mutação Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Surg Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Proteína Supressora de Tumor p53 / Mutação Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Surg Ano de publicação: 2020 Tipo de documento: Article